Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think it's interesting that the last two bits of news caused a fall in PPS! This blows my mind. I don't want to even try to figure out why.
Maybe, maybe not. I think that the patent is simply a stepping stone into greener pastures. But from an investment standpoint, just because I got a patent on turning lead into gold, doesn't mean I have any gold right away. It takes time and investment internally to build the viability and get the product to market.
That is why those of us that are long will hold out and continue to horde our shares. Good things are coming but I prefer a tortoise approach over a cheetah any day. In the end the base is stronger.
It's amazing how many people are selling on news. It doesn't really help the confidence level. Hold strong all!! This one is worth waiting for.
If I only had the ability to day trade I was going to sell at .113 knowing that this would happen. Oh well.
Definitely resistance at .115. I don't knwo that we will get through that without news for today at least.
LOL! I agree with $0.15 first then the bigger numbers.
But, if methadone hits plus one other major piece of news, preferably another launch, then I think $0.15 is LOW and 0.50 may not seem so far fetched. But hell, I'm hoping for $1.
All speculation and dreaming of course.
Well, it looks like our hopes of Methadone shipping this year are going to be smashed. :(
At least we know it will be here soon. I wish there was an update...
I was thinking the same thing but I'm sticking with what I know and hoping this sell of is due to eoy. I'm still buying more. Definitely worth the risk IMO.
Right now I'm hoping it stays down so I have the time to buy more shares.
I think I'll have enough scrounged together for another 10k shares. Not much but if this thing blows, I'll be very happy. I think every dollar invested right now has the potential to increase 10-fold. Maybe more...
News tomorrow would be wonderful.
The anticipation is killing me. I think this week seems like a good week for news.
Looks like the volume is showing the anticipation as well. Would be nice to have a little pump before a news release.
I wonder if we will see .20s again after the two product releases.
Thanks Hike! Now if I could only find another few thousand dollars before Christmas. Sounds like it will be an easy triple at this price.
I had a dream last week that a news release would hit on the 5th. But hey I also had a dream that this thing shot up to $7 per share in a day. Would love to see that but I'll be realistic and hope for $1.
This stock is really looking like it will be .09 until we get some serious news. Even after reporting losses for the quarter it didn't drop a notch. Good to see such support.
The $4 price target has been up on yahoo for awhile but it's a single analyst estimate without much inforamtion surrounding it.
The only way I see Elite hitting $4 in a year is to have all products in the immediate pipeline launch and hit the shelves. Then, on top of that, bring in aroud $200 million in revenue. Slim chance but I guess anything can happen.
Well the good news is that it seems the investors expected these kinds of numbers and we are staying relatively flat in the stock price. I think we are all just waiting...and waiting.... and.
Go FDA go!!!
10Q is out.
Looks a little better than I expected but its nothing extraordinary to pop the price out of this pinch.
If anything we may see a dip before the CC.
Here is a link I have but I do not know if you guys can get to it.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7902954
Reminds me of one of my favorite sayings. "Only the paranoid survive".
Thank you all for the replies. I'm just trying to figure out ways to make the most out of what I have.
I'll probably get blasted for posting a message like this but here it is.
Most of you here seem to have a decent amount invested in this company and for obvious reasons. My question is, are most of you traders by profession or do you have other jobs? I'm new to trading and have only put in a small amount of money compared to most in the trading world. I'm really trying to figure out how to increase my investment amounts without breaking the bank. Does anyone have any tips for building a strong base of liquid assets?
Again sorry if I post this in the wrong place but investors watching this board seem to be pretty real people.
Any advise is appreciated.
I wouldn't be surprised if the numbers aren't great. They have not made much headway for new product lines. I would assume modest growth at less than 10% YOY. We will see though.
IMO this call is not going to make a big difference in the recent flat line on the stock price.
NEW CONFERENCE CALL 11/15/2011
Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operations on Tuesday, November 15, 2011
12:13 pm ET 11/10/2011- GlobeNewswire
NORTHVALE, N.J., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics with high barriers to entry, announced today the Company will host a conference call on Tuesday, November 15, 2011 at 2:00 PM EST to review the second quarter results of operations and provide an update on recent business developments. Company executives will also conduct a question and answer session following their remarks.
To access the conference call:
Domestic callers: (800) 346-7359 International callers: (973) 528-0008 Conference Entry Code: 98840
A digital telephone replay will be available approximately one hour after the conclusion of the call for two weeks until November 29, 2011 by dialing:
Domestic callers: (800) 332-6854 International callers: (973) 528-0005 Conference entry code: 98840
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals ("ECR"), a wholly owned subsidiary of Hi-Tech Pharmacal ("Hi-Tech"). Elite's lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
The Elite Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8737
This news release contains forward-looking statements, including those related to the preliminary nature of the clinical program results and the potential for further product development, that involve known and unknown risks, delays, uncertainties and other factors not under the control of Elite, which may cause actual results, performance or achievements of the companies to be materially different from the results, performance or other expectations implied by these forward-looking statements. In particular, because substantial future testing will be required prior to approval, the results described above may not be supported by additional data or by the results of subsequent trials. These risks and other factors, including the timing or results of pending and future clinical trials, regulatory reviews and approvals by the Food and Drug Administration and other regulatory authorities, and intellectual property protections and defenses, are discussed in Elite's filings with the Securities and Exchange Commission such as the 10K, 10Q and 8K reports. Elite undertakes no obligation to update any forward-looking statements.
CONTACT: For Elite Pharmaceuticals, Inc.Dianne Will, Investor Relations, 518-398-6222 Dianne@elitepharma.comwww.elitepharma.com
Source: Elite Pharmaceuticals, Inc.
I'm definitely not selling short on this one. Just wish I had more money to dump into this thing at this price.
*sigh*
I feel like this is an hourglass. The bottom just keeps drizzling out.
We need news!!
I would think it makes sense to secure the patent before releasing anything into the wild. IMO it's the only way to function as a pharma company who is trying to gain an edge on the market. Also, if they released the drug and someone copied it, the patent would have a new layer of fun to mettle with.
Luckily, the patents have changed in the US to be first come first serve.
So that is a pretty critical patent then. Sounds like this is essential for multiple Elite products.
I'd be willing to guess that this will be the catalyst for the "waves of news" to follow.
Indeed it looks much closer.
Can someone please clarify what drug release this patent is for?
I see that it is for a time release type product so would it be the oxy?
Hopefully in the mean time this doesn't get driven back down into the 7's. I thought there was good support at .09 until today. *Fingers crossed*
Thank you!
I figured that was the case but I wasn't sure if the information was public or not.
I did read the pdf regarding the interview process but was unsure about the disclosure of information beyond the patent office and the applicant.
Hey guys,
I'm new to the board and have been watching this stock for a long time. (All year) I'm looking forward to news as much as everyone else but not sure when to expect it.
One question, with the change on the patent application, do we see the results of the interview or is this something that will occur with none of us knowing?